Funds holding Santen Pharmaceutical Co. Ltd
ISIN US80287P1003 · Japan · LEI 529900TPT3I7C17MIM03
- Fund holders
- 0
This issuer has other securities: Santen Pharmaceutical Co Ltd (JP3336000009)
No tracked fund declares this company in its latest report.
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 56,700 | 0.0 % |
| 2026Q1 | 1 | 0 | 56,700 | +18.9 % |
| 2025Q4 | 1 | 0 | 47,700 | +48.6 % |
| 2025Q3 | 1 | 0 | 32,100 | +154.8 % |
| 2025Q2 | 1 | 0 | 12,600 | +293.8 % |
| 2025Q1 | 1 | 0 | 3,200 | -92.0 % |
| 2024Q2 | 1 | 0 | 40,231 | +1,105.2 % |
| 2024Q1 | 1 | 3,338 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | 333 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Santen Pharmaceutical Co. Ltd". https://titelia.com/en/stocks/santen-pharmaceutical-co-ltd-US80287P1003